GlycoVaxyn is a clinical stage biopharmaceutical company focused on the development and manufacture of next-generation bioconjugate vaccines utilizing its proprietary recombinant DNA technology.

02.04.12 GlycoVaxyn to Present at 2nd Annual Vaccines Congress 2012 28.03.12 GlycoVaxyn to Present at World Congress of Vaccine 2012 09.01.12 GlycoVaxyn to Present at Biotech Showcase 2012

GlycoVaxyn will be present during:

- the World Vaccine Congress in Washington on April 10-13, 2012

- the 2nd Annual Vaccines Congress in London/GB on April 2-3, 2012 (presenting)

- the World Congress of Vaccine in Beijing on March 26-28, 2012 (presenting)